Epidiolex
Total Payments
$3.8M
Transactions
15,954
Doctors
3,565
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $851,371 | 5,227 | 1,842 |
| 2020 | $1.2M | 3,479 | 1,302 |
| 2019 | $1.7M | 7,248 | 2,226 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.7M | 1,088 | 45.6% |
| Unspecified | $621,332 | 28 | 16.4% |
| Consulting Fee | $594,729 | 241 | 15.7% |
| Food and Beverage | $410,963 | 13,711 | 10.8% |
| Grant | $209,539 | 12 | 5.5% |
| Travel and Lodging | $193,609 | 786 | 5.1% |
| Space rental or facility fees (teaching hospital only) | $31,800 | 13 | 0.8% |
| Education | $2,673 | 75 | 0.1% |
Payments by Type
General
$3.2M
15,926 transactions
Research
$621,332
28 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| NYU IIT | Greenwich Biosciences, Inc. | $230,889 | 0 |
| Northwell IIT | Greenwich Biosciences, Inc. | $114,262 | 0 |
| GWEP19022 | GW Research Limited | $112,704 | 0 |
| USF IIT | Greenwich Biosciences, Inc. | $99,145 | 0 |
| Kennedy Krieger IIT | Greenwich Biosciences, Inc. | $64,333 | 0 |
Top Doctors Receiving Payments for Epidiolex — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Neurology with Special Qualifications in Child Neurology | Gulf Breeze, FL | $15,792 | 21 |
| , MD | Neurology | Hattiesburg, MS | $15,584 | 46 |
| , MD | Neurology | Los Angeles, CA | $14,700 | 1 |
| , DO | Neurology | San Antonio, TX | $14,002 | 16 |
| , M.D | Neurology | Atlanta, GA | $13,810 | 30 |
| , MD | Neurology | Grand Junction, CO | $12,514 | 22 |
| , MD | Neurology with Special Qualifications in Child Neurology | Portland, OR | $12,143 | 23 |
| , MD | Neurodevelopmental Disabilities | Hackensack, NJ | $12,063 | 21 |
| , M.D | Internal Medicine | Parker, CO | $11,729 | 32 |
| , MD | Neurodevelopmental Disabilities | Greenwood, SC | $11,300 | 3 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Cleveland, OH | $11,238 | 15 |
| , MD, PHD | Epilepsy | Louisville, KY | $11,238 | 9 |
| , MD | Neurology with Special Qualifications in Child Neurology | Philadelphia, PA | $10,794 | 9 |
| , M.D | Psychiatry | Rockville, MD | $10,750 | 6 |
| , MD | Neurology | Bethesda, MD | $10,453 | 24 |
| , MD | Neurology with Special Qualifications in Child Neurology | Atlanta, GA | $10,215 | 42 |
| , MD | Clinical Neurophysiology | Chicago, IL | $10,024 | 17 |
| , MD | Neurological Surgery | Denver, CO | $9,788 | 15 |
| , M.D | Neurology with Special Qualifications in Child Neurology | San Francisco, CA | $9,672 | 6 |
| , M.D., M.P.H | Psychiatry | La Jolla, CA | $9,434 | 3 |
| , MD | Neurology with Special Qualifications in Child Neurology | Boston, MA | $9,224 | 14 |
| , M.D | Neurodevelopmental Disabilities | Los Angeles, CA | $9,079 | 19 |
| , M.D | Neurology | San Francisco, CA | $8,891 | 23 |
| , M.D | Clinical Neurophysiology | St Petersburg, FL | $8,528 | 13 |
| , MD | Neurology | Cincinnati, OH | $8,520 | 12 |
Ad
Manufacturing Companies
- Greenwich Biosciences, Inc. $3.3M
- GW Research Limited $455,077
- GW Pharma Limited $70,941
Product Information
- Type Drug
- Total Payments $3.8M
- Total Doctors 3,565
- Transactions 15,954
About Epidiolex
Epidiolex is a drug associated with $3.8M in payments to 3,565 healthcare providers, recorded across 15,954 transactions in the CMS Open Payments database. The primary manufacturer is Greenwich Biosciences, Inc..
Payment data is available from 2019 to 2021. In 2021, $851,371 was paid across 5,227 transactions to 1,842 doctors.
The most common payment nature for Epidiolex is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.7M, 45.6% of total).
Epidiolex is associated with 5 research studies, including "NYU IIT" ($230,889).